Teleflex Inc.

Teleflex is a provider of medical technology products. The company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The company's segments include: Vascular North America, which provides Arrow branded catheters and related devices that are used in a range of procedures, including the administration of intravenous of intravenous therapies, the measurement of blood pressure and the withdrawal of blood samples through a single puncture site; and Interventional North America, which provides devices for treating coronary and peripheral vascular disease.
  • TickerTFX
  • ISINUS8793691069
  • ExchangeNew York Stock Exchange
  • SectorHealth Care Equipment & Services
  • CountryUnited States

Analysts

Teleflex Incorporated - June 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Moody's announces completion of a periodic review of ratings of Teleflex Incorporated

Announcement of Periodic Review: Moody's announces completion of a periodic review of ratings of Teleflex Incorporated. Global Credit Research- 27 Jun 2019. New York, June 27, 2019-- Moody's Investors Service has completed a periodic review of the ratings of Teleflex Incorporated and other ratings that are associated with the same analytical unit.

Teleflex Incorporated - March 2019 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Teleflex Incorporated - December 2018 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Teleflex Incorporated - September 2018 (LTM): Peer Snapshot

Compares key performance metrics against industry peers.

Kevin Huang

Teleflex Incorporated

Kevin Huang

Teleflex Incorporated

Kevin Huang

Teleflex Incorporated

Kevin Huang

Teleflex Incorporated

Kevin Huang

Teleflex Incorporated

1 director bought

A director at Teleflex Inc bought 1,250 shares at 285.000USD and the significance rating of the trade was 88/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showing Close periods where trading activity is restricted under listing rules. The names of board...

ValuEngine Rating and Forecast Report for TFX

ValuEngine Rating and Forecast Report for TFX

ValuEngine Rating and Forecast Report for TFX

ValuEngine Rating and Forecast Report for TFX

ValuEngine Rating and Forecast Report for TFX

ValuEngine Rating and Forecast Report for TFX

ValuEngine Rating and Forecast Report for TFX

ValuEngine Rating and Forecast Report for TFX

ValuEngine Rating and Forecast Report for TFX

ValuEngine Rating and Forecast Report for TFX

MarketLine Department

Boston Scientific Corporation - Strategy, SWOT and Corporate Finance Report

Summary Boston Scientific Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key Highlights Boston Scientific Corporation (Boston Scientific) is a manufacturer of medical devices used in interventional medical specialties. The company’s solutions include drug-eluting coronary stent systems, percutaneous coronary interventions (PCI), intravascular catheter-directed ult...

MarketLine Department

Smiths Group plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments

Summary Marketline's Smiths Group plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capital raisings, venture capital investments, ownership and partnership transactions undertaken by Smiths Group plc since January2007. Marketline's Company Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. Key H...

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A number of Restaurant names are staging price and RS reversals or continue to have bullish formations. (ex. CHUY, JACK, CMG) • There are a few healthcare related names that continue to be bright spots and reflect leadership. (ex. CUTR, TFX, BSX, SYK, ADUS, CHE, COO, WST, TRHC, HUM, AMGN, PBH, MRK, and ZTS.) • REITs continue to show leadership characteristics' as many are hitting price and RS highs. (ex. OHI, SBRA, ESS, IRT, and MAA)

Dave Nicoski ...
  • Ross LaDuke

Vital Signs: Actionable charts

Key Points: • A few Consumer Discretionary names continue to act well. The list is thinning of attractive names though. (ex. FOXF, UEIC, DECK, CHDN, WING, YUM, BOOT, RCI, POOL, DLTR, and AAN) • A number of Health Care Sector names are attractive. (ex. MASI, TFX, CNMD, STE, CRVL, LNTH, HAE, COO, WST, RGEN, ANIK, NEO, and TECH) • Attractive Technology and Services names include: MANH, CDNS, ANSS, AGYS, TTEC, CLGX, MMS, and KBR

ResearchPool Subscriptions

Get the most out of your insights

Get in touch